Related Experiment Video
Updated: Aug 15, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
MAPK signalling in rheumatoid joint destruction: can we unravel the puzzle?
Lars-Henrik Meyer1, Thomas Pap
1Division of Molecular Medicine of Musculoskeletal Tissue, Department of Orthopaedics, University Hospital of Munster, Munster, Germany.
Abstract:
Mitogen-activated protein kinases (MAPKs) have been associated with the pathogenesis of rheumatoid arthritis (RA), but the individual contributions of the three MAPK family members are incompletely understood. Although previous data have established a role for c-Jun N-terminal kinase (JNK) and extracellular signal-related kinase (ERK) in different animal models of arthritis, most recent data indicate that the stable activation of p38 MAPK and in part of ERK significantly contributes to destructive arthritis in mice transgenic for human tumour necrosis factor-alpha. These data highlight the complexity of MAPK signalling in arthritis and provide a basis for the design of novel strategies to treat human RA.
Insights
Mitogen-activated protein kinases (MAPKs) are implicated in rheumatoid arthritis (RA) pathogenesis. Stable activation of p38 MAPK and extracellular signal-related kinase (ERK) significantly contributes to destructive arthritis in a mouse model.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- Rheumatoid arthritis (RA) pathogenesis involves complex signaling pathways.
- Mitogen-activated protein kinases (MAPKs) are key regulators of cellular responses.
- The specific roles of different MAPK family members in RA are not fully elucidated.
Discussion:
- Previous studies implicated c-Jun N-terminal kinase (JNK) and extracellular signal-related kinase (ERK) in arthritis models.
- Recent findings demonstrate that sustained p38 MAPK activation is crucial for destructive arthritis.
- Extracellular signal-related kinase (ERK) also plays a partial role in disease progression.
Key Insights:
- p38 MAPK and, to some extent, ERK are significantly involved in TNF-alpha-induced destructive arthritis.
- The interplay between different MAPK pathways in RA is complex.
- Understanding these pathways is vital for developing targeted RA therapies.
Outlook:
- Further research into MAPK signaling in RA can inform the development of novel therapeutic strategies.
- Targeting specific MAPK pathways may offer a new approach to treating rheumatoid arthritis.
- Investigating the precise contributions of each MAPK member could lead to more effective RA treatments.
Related Concept Videos
The JAK-STAT Signaling Pathway
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction